News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
294 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17922)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Corindus Vascular Robotics Reports Third Quarter 2017 Results
Revenue for the third quarter of 2017 was $2.4 million compared to $0.7 million for the same period in the prior year.
November 7, 2017
·
9 min read
Business
Invuity Reports 2017 Third Quarter Financial Results
Revenue was $9.6 million in the third quarter of 2017, up 13% from revenue of $8.5 million in the third quarter of 2016 driven by an increase in active accounts. Management estimates that approximately $400,000 in revenue was lost due to the impact of hurricanes.
November 7, 2017
·
10 min read
Business
Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO
OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company.
November 7, 2017
·
6 min read
Business
Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results
Navidea reported total revenues for the quarter of $224,000.
November 7, 2017
·
12 min read
Policy
Caris Life Sciences Files Patent Infringement Suit Against Foundation Medicine, Inc.
Caris is seeking damages and other relief for Foundation’s willful infringement of Caris’ patent rights by its FoundationOne, FoundationACT and FoundationOne Heme products.
November 7, 2017
·
2 min read
Business
Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program
Dr. Mozaffarian is a renowned researcher whose widely published work focuses on how diets such as those rich in omega-3s and lifestyle can influence cardiometabolic health.
November 7, 2017
·
6 min read
BIT Group to Display Molecular Instrumentation Solutions at AMP 2017
The AMP Annual Meeting is recognized as the premier gathering for molecular professionals as they seek to obtain critical, analytical patient care intelligence.
November 7, 2017
·
2 min read
Business
Taro Provides Results for September 30, 2017
Cash flow provided by operations for the six months ended September 30, 2017, was $138.7 million compared to $192.7 million for the six months ended September 30, 2016.
November 7, 2017
·
12 min read
Business
Dermira Reports Third Quarter 2017 Financial Results and Announces that FDA Accepts New Drug Application for Glycopyrronium Tosylate for the Treatment of Patients With Primary Axillary Hyperhidrosis
The FDA’s decision on New Drug Application expected by June 30, 2018.
November 7, 2017
·
15 min read
Deals
Spero Therapeutics Announces Closing of Initial Public Offering
The company has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its common stock at the initial public offering price.
November 7, 2017
·
1 min read
Previous
22 of 30
Next